Dimensional Fund Advisors LP Concert Pharmaceuticals, Inc. Transaction History

Dimensional Fund Advisors LP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	BUY	$4.34 - $5.84 $489,647 - $658,880	112,822 Added 17.04%	774,922 $4.53 Million
Q3 2022 Nov 10, 2022	SELL	$4.27 - $7.2 $657,891 - $1.11 Million	-154,073 Reduced 18.88%	662,100 $4.44 Million
Q2 2022 Aug 12, 2022	BUY	$2.8 - $6.36 $105,215 - $238,989	37,577 Added 4.83%	816,173 $3.44 Million
Q1 2022 May 13, 2022	BUY	$2.73 - $3.94 $174,337 - $251,608	63,860 Added 8.93%	778,596 $2.62 Million
Q4 2021 Feb 09, 2022	SELL	$2.69 - $4.22 $77,033 - $120,848	-28,637 Reduced 3.85%	714,736 $2.25 Million
Q3 2021 Nov 12, 2021	SELL	$3.17 - $4.15 $435,849 - $570,591	-137,492 Reduced 15.61%	743,373 $2.43 Million
Q2 2021 Aug 12, 2021	SELL	$3.77 - $5.24 $477,395 - $663,541	-126,630 Reduced 12.57%	880,865 $3.72 Million
Q1 2021 May 14, 2021	SELL	$4.86 - $13.07 $348,340 - $936,792	-71,675 Reduced 6.64%	1,007,495 $5.03 Million
Q4 2020 Feb 25, 2021	BUY	$9.48 - $12.84 $10.2 Million - $13.9 Million	1,079,170 New	1,079,170 $13.6 Million

Ticker CNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,934,600
Description
Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.